THROMBOSIS RESEARCH

Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs.

Neutrophil extracellular traps in thrombi retrieved during interventional treatment of ischemic arterial diseases.

Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays.

The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.

Accuracy of heparin-induced platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia.

Modulation of the mammalian coagulation system by venoms and other proteins from snakes, arthropods, nematodes and insects.

Non-invasive imaging techniques for the differentiation of acute and chronic thrombosis.

High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A.

Differences between patient-driven adherence to vitamin K antagonists and direct oral anticoagulants. Do few missed doses matter? ACO-MEMS Study.

The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies.

Comprehensive functional exercises with patient education for the prevention of venous thrombosis after major gynecologic surgery: A randomized controlled study.

Individual variations in platelet reactivity towards ADP, epinephrine, collagen and nitric oxide, and the association to arterial function in young, healthy adults.

Differences between metabolically healthy and unhealthy obesity in PAI-1 level: Fibrinolysis, body size phenotypes and metabolism.

Dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A Danish nationwide cohort study.

Sex difference in fibrin clot lysability: Association with coronary plaque composition.

Cardiovascular event rates and trajectories of LDL-cholesterol levels and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease: A population-based cohort study.

Hemoglobin concentration and risk of arterial and venous thrombosis in 1.5 million Swedish and Danish blood donors.

Molecular basis of SERPINC1 mutations in Japanese patients with antithrombin deficiency.

Increasing use of anticoagulants in Germany and its impact on hospitalization for gastrointestinal bleeding.

Trends of cancer-associated venous thromboembolism (VTE) in the United States (2005-2014).

Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy.

SERPINC1 variants causing hereditary antithrombin deficiency in a Danish population.

Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.

Patient experience of pregnancy-related venous thrombosis: A phenomenological study.

Extended treatment of cancer-associated thrombosis.

Worse 12-month prognosis in women with non-valvular atrial fibrillation undergoing percutaneous coronary intervention.

Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.

DTI/DXI interferences with global coagulation tests in emergency hospital admissions - Results of the prospective Dresden NOAC Registry (NCT01588119).

P8. Abstract Title: Inpatient Inherited Thrombophilia Testing a Multicenter Retrospective Review of Practice Patterns and Indications

The effect of red blood cell transfusion on platelet function in critically ill patients.

Vascular and hemostatic alterations associated with pulmonary hypertension in β-thalassemia hemoglobin E patients receiving regular transfusion and iron chelation.

Initiation of statins and risk of venous thromboembolism: Population-based matched cohort study.

The effect of normobaric hypoxic exposure on coagulation as measured by thromboelastography.

Comparison of 10-mg and 5-mg warfarin initiation nomograms in a South Indian population - An open label trial.

Family history of venous thromboembolism in the paediatric population: The need for a standardized definition.

Venothromboembolic signs and medical eponyms: Part II.

High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolism.

In-vitro assessment of the thrombolytic efficacy of therapeutic ultrasound.

Cost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in Thailand.

Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia - Need for a higher than recommended weight-based dosing.

aCL/β2GPI and aPS/PT show synergic thrombogenic effects in suppressing anticoagulant activity of APC and stimulating tissue factor expression and TNF-α secretion by mononuclear cells.

The stressed vascular barrier and coagulation - The impact of key glycocalyx components on in vitro clot formation.